Basic Plaquenil Information

• INN (International Nonproprietary Name): Hydroxychloroquine.

• Brand Names Available In Canada (English): Plaquenil is the most commonly dispensed film-coated tablet 200 mg.

  Generic hydroxychloroquine sulfate products are also widely available in Canada, and Apotex is a listed Canadian supplier.

  Other international brands include Dolquine, Quensyl, Axemal, and Hydroxychloroquine Winthrop, though those are not the typical Canadian packaging names.

• ATC Code: P01BA02 (antiparasitic aminoquinoline, hydroxychloroquine).

• Forms & Dosages: Film-coated tablet, 200 mg, commonly packaged in blister packs (30, 60) or bottles (60, 100).

  Lower-strength 100 mg tablets exist in some markets but are rare.

• Manufacturers In Canada (English): Sanofi (Plaquenil) is the global originator and Apotex supplies generic hydroxychloroquine in Canada.

• Registration Status In Canada (English): Prescription (Rx) only and regulated by Health Canada.

• OTC / Rx Classification: Rx only in Canada; a valid prescription and pharmacist counselling are required for dispensing.

Critical Warnings & Restrictions In Canada

High-Risk Groups (Elderly, Pregnant, Indigenous Health Considerations)

Hydroxychloroquine carries specific safety priorities in Canadian practice, with retinal toxicity and cardiac arrhythmia among the most serious risks.

Older adults have an increased risk of retinal toxicity and cardiac complications when using hydroxychloroquine.

People with pre-existing maculopathy or conduction disease require careful review and specialist input before starting hydroxychloroquine.

Pregnant and breastfeeding people should use hydroxychloroquine only when benefits outweigh risks and after discussion with obstetric and specialist teams.

Children are dosed by weight and full-strength 200 mg tablets pose overdose hazards, so paediatric prescribing should be specialist-led.

Patients in rural and Indigenous communities with limited access to timely ophthalmology or cardiology follow-up need extra planning and documented access to local services before initiation.

• Older Adults — retinal and cardiac risk.
• Pre-existing Maculopathy — avoid or refer to ophthalmology.
• Cardiac Conduction Disease — ECG and cardiology review if indicated.
• Pregnancy/Breastfeeding — use only if necessary and coordinated with specialists.
• Children — weight-based dosing and overdose prevention.
• Rural/Indigenous Communities — ensure local follow-up is available.

Checklist — Pre-Treatment Safety Steps:

• Confirm indication and document informed consent.
• Arrange baseline ophthalmology assessment and plan follow-up.
• Review cardiac history and current QT‑prolonging medications; obtain ECG if cardiac risk present.
• Check liver and kidney function and plan periodic monitoring.
• Provide explicit storage and childproofing instructions to prevent accidental ingestion.

Patient Counselling Handout:

• Take as prescribed; do not double doses.
• Report any vision changes, palpitations, fainting, severe nausea, or neurologic symptoms immediately.
• Keep medication in original container away from children.
• Attend scheduled eye exams and any requested ECG or bloodwork.

Q&A — “Can I Drive After Taking It In Canada?”

Short answer: Only if you feel alert and vision is normal.

If you experience dizziness, blurred vision, sedation, or symptoms of arrhythmia such as palpitations or syncope, do not drive and seek medical assessment.

Document driving advice in counselling notes and advise fitness-for-duty assessment for safety-sensitive occupations as required by employers or occupational health in Canada.

Usage Basics For Canadians

INN, Brand Names Available In Canada

Hydroxychloroquine is the INN and Plaquenil is the most commonly dispensed Plaquenil tablets in Canadian pharmacies.

Generics labelled hydroxychloroquine sulfate are widely available, and typical packaging is Plaquenil 200 mg film-coated tablets in blister packs or bottles.

Apotex is a known local manufacturer and supplier of generic hydroxychloroquine in Canada.

• Plaquenil 200 mg film-coated tablets — blister (30, 60) or bottle (60, 100).
• Generic hydroxychloroquine sulfate 200 mg tablets — similar packaging formats.
• Occasional 100 mg tablets in other markets are rare in Canada.

Legal Classification Under Health Canada (Prescription Vs OTC)

Hydroxychloroquine is classified as prescription-only by Health Canada and requires a valid prescription for dispensing.

Some provincial drug plans require prior authorization or special authority for coverage depending on the indication.

INN

Hydroxychloroquine.

Brand

Plaquenil and generics (hydroxychloroquine sulfate).

Dosage Form

Film-coated tablets, 200 mg; blister packs or bottles are usual.

Always verify the Drug Identification Number (DIN) on the label and check provincial formulary entries before substitution.

Where applicable, bilingual labelling applies in Quebec and customers should consult the prescriber or pharmacist for substitution questions.

Canadian Dosing Guide

Standard Regimens (Health Canada Approved)

For malaria prophylaxis, the usual adult dose is 400 mg weekly, starting 1 to 2 weeks before travel and continuing for 4 weeks after return.

For malaria treatment, a commonly cited regimen is an initial 800 mg followed by 400 mg at 6, 24 and 48 hours, with weight-based adjustments for children.

For rheumatoid arthritis and systemic lupus erythematosus, typical adult dosing is 200 to 400 mg daily, single or divided, with many guidelines capping at approximately 400 mg daily.

Pediatric dosing is weight-based and often given as 3–7 mg/kg/day with a maximum of 400 mg per day, and specialist oversight is recommended.

Adjustments For Comorbidities (E.g., Diabetes)

Dose reduction or increased monitoring should be considered for patients with renal or hepatic impairment, advanced age, or low body weight.

People with diabetes need regular retinal screening and coordination with diabetes care to manage glycaemic control while on hydroxychloroquine.

Cardiac disease or concomitant QT‑prolonging medications require ECG assessment and cardiology input where indicated.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Take the missed dose as soon as you remember unless it is close to the time for your next dose; do not double up doses.

Coverage and replacement of missed refills depend on provincial plan rules and prior authorizations.

Contact the dispensing pharmacist or the relevant provincial drug program (for example, Ontario Drug Benefit, PharmaCare, RAMQ) for help with authorization and access.

• If dose missed — take when remembered and do not double.
• If stock issue — ask the pharmacist about therapeutic alternatives or emergency supply rules.

Interaction Chart (Canadian Context)

Food And Drinks (Coffee, Alcohol In Canadian Lifestyle)

Hydroxychloroquine has no major interaction with coffee, and taking it with food helps reduce gastrointestinal upset.

Alcohol does not directly change hydroxychloroquine pharmacology, but excessive alcohol intake can worsen liver disease or neuropathy and interfere with adherence.

Advise patients with hepatic impairment to limit alcohol and to discuss liver monitoring with their prescriber.

• Take with food or a snack to reduce nausea.
• Avoid excessive alcohol while on long-term therapy if liver disease is present.

Common Drug Conflicts (Refer To Health Canada Advisories)

Pharmacist Checklist Before Dispensing:

• Review full medication list for QT‑prolonging agents.
• Obtain cardiac history and recent ECG if risks are present.
• Check for other 4‑aminoquinoline use and counsel against concomitant use.
• Refer to the latest Health Canada safety communications and perform ECG where indicated.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Patients report common themes on provincial forums, Reddit condition communities, and condition-specific sites such as PatientsLikeMe.

Common sentiments include gastrointestinal side effects, concerns about retinal screening access, and occasional supply or prior-authorization frustrations.

There is particular worry among rural and Indigenous populations about timely ophthalmology and cardiology follow-up.

• GI upset and tolerability concerns.
• Access and supply issues during occasional shortages.
• Access barriers to baseline and follow-up retinal screening in remote areas.

Community Pharmacy Feedback

Community pharmacists report that generics have generally returned to wide availability after pandemic-related strains, though short supply can still occur.

Pharmacists commonly handle prior authorization paperwork and coordinate monitoring, counselling and lab referrals for patients starting hydroxychloroquine.

Note that patient reports are anecdotal and should inform counselling but not replace Health Canada guidance and clinical evidence.

Access & Purchase Options

National Pharmacy Chains

Plaquenil and generics are dispensed at national chains such as Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu, and at independent community pharmacies across Canada.

Steps to obtain hydroxychloroquine typically include obtaining a prescription, presenting it at a pharmacy, discussing coverage and prior authorization, and arranging baseline monitoring referrals.

1. See a prescriber for a valid prescription.
2. Present the prescription to the pharmacy and ask the pharmacist to check coverage.
3. Work with the pharmacy to submit any required prior authorization to the provincial plan.
4. Arrange baseline ophthalmology, ECG, or lab tests as advised.

Online Pharmacies In Canada & Provincial Restrictions

Licensed Canadian online pharmacies will dispense hydroxychloroquine with a valid prescription and must comply with provincial college rules for dispensing and documentation.

Out‑of‑country online suppliers are not recommended because of authenticity and regulatory risk.

In our online pharmacy, plaquenil is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Checklist For Online Orders:

• Verify the pharmacy licence and contact details.
• Confirm the DIN and manufacturer on the product label when it arrives.
• Ensure counselling and documentation are provided by a Canadian-licensed pharmacist.
• Use secure packaging to protect tablets from moisture during shipping.

Patient assistance programs or manufacturer supports may be available for eligible patients and can be explored with the pharmacist.

Mechanism & Pharmacology

Simplified Explanation (Patient-Friendly)

Hydroxychloroquine is an aminoquinoline that accumulates in tissues, notably the skin and the retina.

It modulates immune cell signalling and lysosomal activity, which helps reduce inflammation and flares in autoimmune diseases such as SLE and RA.

Its antiprotozoal action underlies its use for malaria prevention and treatment in appropriate regions.

INN

Hydroxychloroquine.

Half-Life

Long terminal half-life with tissue accumulation and delayed steady-state over weeks.

Tissue Sequestration

Explains delayed onset of benefit and prolonged persistence after stopping.

Retinal Toxicity

Risk increases with cumulative exposure and older age.

Clinical Terms (Health Canada Approved Monograph References)

The ATC classification is P01BA02, in the aminoquinoline antiprotozoal group.

Long-term tissue accumulation explains why clinical benefit for autoimmune disease may take 1–2 months and why retinal monitoring is necessary even with stable dosing.

Use patient analogies such as “it builds up slowly like a long-term vitamin” to explain delayed benefit while emphasising the need for ongoing monitoring.

Indications & Off-Label Uses In Canada

Approved Indications (DIN)

Common Off-Label Practices (Canadian Physicians)

Canadian specialists may prescribe hydroxychloroquine off-label for certain dermatologic autoimmune disorders or juvenile idiopathic arthritis under specialist guidance.

COVID-19 is not recommended as an indication due to lack of proven efficacy and documented harms.

• Dermatologic autoimmune diseases — specialist-guided, evidence varying by condition.
• Juvenile idiopathic arthritis — weight-based dosing with specialist oversight.
• COVID-19 — not recommended and outside accepted practice.

Off-label prescribing requires informed consent and documentation, and provincial formulary criteria may limit coverage without special authorization.

Key Clinical Findings

Canadian And International Studies 2022–2025

Robust long-term data support hydroxychloroquine’s benefit in SLE and RA for reducing disease activity and flare frequency.

Retinal toxicity risk is associated with cumulative dose and duration, with higher risk after approximately five years or at higher mg/kg dosing.

Large trials did not demonstrate benefit for COVID-19 and highlighted cardiac safety concerns when used for that purpose.

Cardiac adverse events, including QT prolongation and rare arrhythmias, have been reported especially when combined with other QT-prolonging drugs.

• Study types summarised include randomized controlled trials, cohort studies, and pharmacovigilance reports.

Ongoing Health Canada Safety Monitoring

Health Canada conducts post-market surveillance and clinicians are encouraged to report adverse events via MedEffect Canada.

Provincial safety advisories may recommend baseline ECG or ophthalmology referral before starting hydroxychloroquine in higher-risk patients.

Checklist For Clinicians:

• Report suspected adverse events through MedEffect Canada.
• Arrange baseline ophthalmology and ECG where appropriate.
• Schedule follow-up intervals based on cumulative exposure and patient risk factors.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Pros And Cons Checklist

• Hydroxychloroquine: relatively low immunosuppression, pregnancy-friendly in SLE, but requires retinal monitoring.
• Methotrexate: more potent but teratogenic and requires extensive lab monitoring.
• Biologics: high efficacy for severe disease but greater cost and infection risk.
• Switching therapies should involve shared decision-making with rheumatology or infectious disease specialists as appropriate.

Common Questions From Canadian Patients

How long until it works? Typically 1–2 months for autoimmune benefits.

How often are eye exams? Baseline exam, then yearly after five years of use or sooner with risk factors.

Pregnancy and breastfeeding? Use only if benefits outweigh risks and after discussion with obstetrician and specialist; hydroxychloroquine is often preferred over other DMARDs for pregnant patients with SLE under specialist guidance.

Can children take it? Yes, but dosing is weight-based and paediatric use should be under specialist oversight.

What are red flags? New vision changes, palpitations, fainting, sudden severe GI upset, or neurologic symptoms warrant urgent assessment.

Will provincial drug plans cover it? Coverage varies by indication and province; consult the pharmacist and your provincial plan about prior authorization and formulary criteria.

Useful Links: consult Health Canada and provincial formularies for up-to-date coverage information and guidance.

Coverage & Purchase Comparison Table

Step-By-Step Purchase Checklist For Canadian Patients

1. Obtain a valid prescription from your prescriber.
2. Ask the pharmacist to verify the DIN and provincial formulary listing.
3. Submit prior authorization requests if required by your plan.
4. Confirm patient cost and ask about generic Plaquenil tablets or hydroxychloroquine sulfate tablets to reduce expense.
5. Arrange baseline ophthalmology and ECG referrals before starting long-term therapy.

Registration & Regulation

Health Canada Approval

Hydroxychloroquine is approved and regulated by Health Canada as a prescription medicine and products carry a Drug Identification Number (DIN).

Plaquenil 200 mg film-coated tablets are commonly referenced in product monographs and Canadian supplies include generics such as Apotex versions.

Dispensing must follow provincial college standards and off-label use should be justified and documented by the prescriber.

DIN Number And Labelling Requirements

Patients should check the DIN, manufacturer, lot number and expiry on the medication label when receiving hydroxychloroquine.

Labels in Quebec and other bilingual regions may appear in both English and French as required by provincial regulation.

Checklist Of Label Items To Verify:

• Product name and strength (e.g., Plaquenil 200 mg).
• DIN and manufacturer name.
• Lot number and expiry date.
• Dispensing directions and warnings.

Clinicians should maintain records of prescriptions, monitoring and any adverse event reporting to MedEffect Canada as required.

Storage & Handling

Standard Canadian Household Conditions

Store hydroxychloroquine at room temperature between 15–30°C (59–86°F) in the original container away from moisture and direct light.

Keep all medications out of reach and sight of children, as accidental ingestion can be fatal especially in paediatric patients.

When travelling across Canadian climates, avoid leaving tablets in vehicles where freezing or high heat could occur.

Cold-Chain Requirements (Where Applicable)

No cold-chain is required for hydroxychloroquine, but tablets should be protected from freezing and prolonged high humidity.

When ordering online, ensure packaging prevents moisture exposure during transit.

Storage Checklist For Patients:

• Keep in original container with childproof cap where available.
• Store in a cool, dry cupboard away from bathrooms and kitchen steam.
• If tablets become wet or damaged, return them to the pharmacy and obtain a replacement.

Disposal: return unused tablets to a pharmacy take-back program or follow local medication disposal guidance.

Guidelines For Proper Use

Canadian Pharmacist Guidance

Pharmacists should verify indication, allergies, and a complete medication list including QT‑prolonging drugs before dispensing hydroxychloroquine.

Counselling should cover dosing, missed-dose instructions, common side effects, red flags for urgent care, and storage precautions.

Document counselling in the patient record and confirm a plan for baseline ophthalmology referral and any required ECG.

Pharmacist Counselling Checklist:

• Explain dose and schedule, including Plaquenil 200 mg tablet counts needed.
• Review missed-dose guidance and overdose warnings, especially for children.
• Highlight red flags: vision changes, palpitations, syncope, severe GI or neurologic symptoms.
• Confirm monitoring schedule for eye exams and ECG where indicated.

Provincial Health Authority Recommendations

Follow provincial formularies and specialist guidance for initiation and monitoring of hydroxychloroquine therapy.

Typical monitoring framework includes a baseline eye exam, weight-based dosing review, baseline ECG if cardiac risk or interacting medications exist, and repeat ophthalmology annually after five years or earlier with risk factors.

Provide the patient with a clear red-flag list and instructions for reporting adverse events to their clinician and to Health Canada.

Offer referral templates and a sample patient handout that includes dosing, storage, monitoring timeline and emergency contact instructions.

Delivery Across Canada (English)